GTS Securities’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

GTS Securities’s Portfolio LABD Stock Details LABD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$590K	Buy	76,580 +34,219	+81%	+$461K	0.01%	638
2026 Q1	$690K	Sell	42,361 -152	-0.4%	-$2.88K	0.02%	553
2025 Q4	$895K	Buy	+42,513	New	+$1.15M	0.03%	488
2025 Q3	–	Sell	-2,033	Closed	-$152K	–	1601
2025 Q2	$152K	Buy	+2,033	New	+$180K	0.01%	1141
2025 Q1	–	Sell	-3,536	Closed	-$256K	–	1441
2024 Q4	$256K	Sell	3,536 -4,877	-58%	-$298K	0.01%	976
2024 Q3	$491K	Buy	8,413 +3,699	+78%	+$225K	﹤0.01%	2841
2024 Q2	$346K	Sell	4,714 -4,588	-49%	-$387K	﹤0.01%	3004
2024 Q1	$678K	Buy	9,302 +5,426	+140%	+$453K	﹤0.01%	2309
2023 Q4	$376K	Sell	3,876 -812	-17%	-$158K	﹤0.01%	3022
2023 Q3	$966K	Buy	4,688 +1,961	+72%	+$319K	﹤0.01%	2041
2023 Q2	$392K	Buy	+2,727	New	+$407K	0.01%	765

Other funds holding LABD

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Jump Financial Chicago, Illinois $12.4B AUM 62.79% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

GTS Securities's LABD Position: Q2 2026 in Review

GTS Securities increased its Direxion Daily S&P Biotech Bear 3X ETF (LABD) stake by 81% in Q2 2026, buying an estimated $461K and bringing the position to 76,580 shares worth $590K. The position accounts for 0.01% of the portfolio, ranked #638.

GTS Securities first reported a position in LABD in Q2 2023 and has held it in 11 quarters since. The position peaked at $966K in Q3 2023. 21 funds tracked by Wall St. Rank hold LABD as of Q2 2026.

GTS Securities held 76,580 shares of Direxion Daily S&P Biotech Bear 3X ETF worth $590K as of Q2 2026.
GTS Securities bought 34,219 Direxion Daily S&P Biotech Bear 3X ETF shares in Q2 2026, an estimated $461K.
Direxion Daily S&P Biotech Bear 3X ETF made up 0.01% of GTS Securities's portfolio in Q2 2026, its #638 holding.
GTS Securities first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q2 2023 and has held it in 11 quarters since.
GTS Securities's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $966K in Q3 2023.
21 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.